AAAAAA

   
Results: 1-7 |
Results: 7
First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia
Authors: Clavio, M Gatto, S Beltrami, G Cerri, R Carrara, P Pierri, I Canepa, L Miglino, M Balleari, E Masoudi, B Damasio, E Ghio, R Sessarego, M Gobbi, M
Citation: M. Clavio et al., First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia, LEUK LYMPH, 40(3-4), 2001, pp. 305-313
Lymphoplasmacytic lymphoma immunocytoma: Towards a disease-targeted treatment?
Authors: Clavio, M Quintino, S Venturino, C Ballerini, F Varaldo, R Gatto, S Galbusera, V Garrone, A Grasso, R Canepa, L Miglino, M Pierri, I Gobbi, M
Citation: M. Clavio et al., Lymphoplasmacytic lymphoma immunocytoma: Towards a disease-targeted treatment?, J EXP CL C, 20(3), 2001, pp. 351-358
Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens
Authors: Clavio, M Quintino, S Masoudi, B Carrara, S Cerri, R Pierri, I Canepa, L Miglino, M Muner, P Damasio, E Gobbi, M
Citation: M. Clavio et al., Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens, J EXP CL C, 20(2), 2001, pp. 165-173
Detection of minimal residual disease in B-lymphoproliferative disorders: A three step SSCP-PCR method
Authors: Miglino, M Grasso, R Pietrasanta, D Palmisano, GL Berisso, G Clavio, M Pierri, I Santini, G Canepa, L Gobbi, M
Citation: M. Miglino et al., Detection of minimal residual disease in B-lymphoproliferative disorders: A three step SSCP-PCR method, J EXP CL C, 20(1), 2001, pp. 95-101
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation
Authors: Miglino, M Santini, G Grasso, R Pietrasanta, D Clavio, M Pierri, I Canepa, L Nati, S Ballerini, F Varaldo, R Palmisano, G Gobbi, M
Citation: M. Miglino et al., Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation, HAEMATOLOG, 86(7), 2001, pp. 706-714
Thalidomide in agnogenic and secondary myelofibrosis
Authors: Canepa, L Ballerini, F Varaldo, R Quintino, S Reni, L Clavio, M Miglino, M Pierri, I Gobbi, M
Citation: L. Canepa et al., Thalidomide in agnogenic and secondary myelofibrosis, BR J HAEM, 115(2), 2001, pp. 313-315
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly
Authors: Pierri, I Clavio, M Beltrami, G Cavaliere, M Lanza, L Miglino, M Canepa, L Pietrasanta, D Ballerini, F Quintino, S Gatto, S Celesti, L Carrara, P Varese, P Gobbi, M
Citation: I. Pierri et al., GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly, J EXP CL C, 18(1), 1999, pp. 55-60
Risultati: 1-7 |